ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• The Transformative Impact Of EDC Systems In 2025

  The shift towards decentralized and hybrid trials underscores the significance of EDC in expanding geographic reach, fostering diversity in participant populations, and reduce participant burden.

• eTMFs Uncovered: 5 Costly Misconceptions To Avoid

  Critically examine prevalent myths surrounding electronic Trial Master Files (eTMFs) and their integration with electronic Investigator Site Files (eISFs).

• Developing Drugs For Rare Diseases: Generating Clinical Evidence

  For rare diseases, scientific breakthroughs often stall before reaching patients. A new approach to generating clinical evidence could change that trajectory.

• Endpoint Reliability And eCOA Solutions Facilitate CNS Trial Success

  A Japan-based pharmaceutical development company utilized Signant's eCOA solutions and knowledge to ensure the reliability of endpoints in their Phase 3 and extended-duration CNS trials.

• Accelerating Your New Therapies Path To Market With Automation

  Automation has become an essential tool for addressing the inefficiencies in traditional clinical trial methodologies, enabling trial teams to instead concentrate on critical tasks such as patient care.

• The Value Of Tokenizing Clinical Development Data

  Most use cases of real-world data don’t require tokenization to deliver value. However, given industry challenges and the influx of information, see how ROI can be achieved from trial data tokenization.

• PEAK Matrix® For Decentralized Clinical Trial Platforms Provider 2023

  Explore how technological advancements, innovative business models, increased wearables support, FDA’s push to the industry to adopt DCTs, and a holistic approach to clinical trials have proliferated the DCT landscape.

• Managing Risk And Regulation In Clinical Trial Technology

  Now is the time to evaluate your current risk management framework. Take action today to strengthen your safeguards, tailor your risk assessments, and prioritize transparent patient engagement.

• What Is Patient Payments For Clinical Trials?

  Late or missing reimbursements push patients out of trials. Real-time, flexible payments help keep them engaged and reduce site workload.

• The Significance Of Quality Data In Meeting FDA Regulatory Scrutiny

  Data Science expert Rod McGlashing explains how scrutiny from the FDA spurs regulatory compliance, resulting in better data quality and the creation of optimal applications for intellectual property.